...
首页> 外文期刊>Journal of endourology >Safety and efficacy of supracostal access in tubeless percutaneous nephrolithotomy.
【24h】

Safety and efficacy of supracostal access in tubeless percutaneous nephrolithotomy.

机译:肋膜上入路在无管经皮肾镜取石术中的安全性和有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the feasibility and safety of supracostal access in tubeless percutaneous nephrolithotomy (PCNL). PATIENTS AND METHODS: From September 2004 to November 2005, tubeless PCNL using supracostal access was done for 72 patients at our institute. Patients requiring more than two percutaneous tracts or with significant intraoperative bleeding or residual stone burden were excluded from the study. The outcome of these patients was compared with that of a historic cohort of similar patients having supracostal access with routine placement of a nephrostomy tube. The two groups had comparable demographic data. RESULTS: The differences in the mean drop in hemoglobin concentration, transfusion requirement, and complication rate in the two groups were not statistically significant, with three patients in the study group and four patients in the control group requiring blood transfusion. Patients undergoing tubeless PCNL required less analgesia (P = 0.000) and were discharged a mean of 19 hours earlier (P = 0.000) than those in the control group. Complete stone clearance was achieved in 90.27% of the renal units in the study group and 86.11% of the renal units in the control group. Two patients in the study group and three patients in the control group had postoperative hydrothorax, all of whom, except for one in the control group, were managed conservatively. CONCLUSION: Supracostal access in tubeless PCNL appears to be feasible, safe, and effective, offering the advantages of a lower analgesic requirement and shorter hospital stay without increasing thoracic complications. Studies with larger numbers of patients are needed to confirm these initial findings.
机译:目的:评估在无管经皮肾镜取石术(PCNL)中肋上入路的可行性和安全性。患者与方法:自2004年9月至2005年11月,本研究所对72例患者进行了采用肋上入路的无管PCNL。该研究排除了需要两个以上经皮道或术中有明显出血或残余结石负担的患者。将这些患者的结果与历史上类似的同类患者进行结直肠上管常规置入的方法进行比较。两组人口统计数据可比。结果:两组的平均血红蛋白浓度下降,输血需求和并发症发生率差异无统计学意义,研究组三例和对照组四例需要输血。与对照组相比,接受无管PCNL的患者需要较少的镇痛(P = 0.000),平均出院时间要早19小时(P = 0.000)。在研究组中,肾单位的结石清除率达到了90.27%,在对照组中,肾单位的结石清除率达到了86.11%。研究组中有2例患者和对照组中有3例患者进行了胸腔积液,除对照组中的1例以外,所有患者均接受了保守治疗。结论:无管PCNL的肋膜上入路似乎是可行,安全和有效的,具有以下优点:镇痛要求较低,住院时间较短,而不会增加胸腔并发症。需要对更多患者进行研究以确认这些初步发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号